The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease Inhibitors

Direct-acting antiviral (DAA) therapies have revolutionised the treatment of hepatitis C virus (HCV). The financial cost of DAAs however is significant, and first generation protease inhibitors (PIs) also require frequent monitoring of viral RNA levels to guide treatment. In this context, we examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Linh Thuy, Gray, Emma, O'Leary, Aisling, Carr, Michael, De Gascun, Cillian F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053597/
https://www.ncbi.nlm.nih.gov/pubmed/27711230
http://dx.doi.org/10.1371/journal.pone.0163900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053597/
https://www.ncbi.nlm.nih.gov/pubmed/27711230
http://dx.doi.org/10.1371/journal.pone.0163900

Ejemplares similares